Cargando…
Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer’s Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue
Docosahexaenoic acid (DHA), an omega-3 fatty acid rich in seafood, is linked to Alzheimer’s Disease via strong epidemiological and pre-clinical evidence, yet fish oil or other DHA supplementation has not consistently shown benefit to the prevention or treatment of Alzheimer’s Disease. Furthermore, a...
Autores principales: | Heath, Rory J., Wood, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584218/ https://www.ncbi.nlm.nih.gov/pubmed/34769257 http://dx.doi.org/10.3390/ijms222111826 |
Ejemplares similares
-
The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer's Disease
por: Grimm, Marcus O. W., et al.
Publicado: (2013) -
A maternal erythrocyte DHA content of approximately 6 g% is the DHA status at which intrauterine DHA biomagnifications turns into bioattenuation and postnatal infant DHA equilibrium is reached
por: Luxwolda, Martine F., et al.
Publicado: (2011) -
Comparative analyses of DHA-Phosphatidylcholine and recombination of DHA-Triglyceride with Egg-Phosphatidylcholine or Glycerylphosphorylcholine on DHA repletion in n-3 deficient mice
por: Wu, Fang, et al.
Publicado: (2017) -
The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients
por: Morin, Caroline, et al.
Publicado: (2018) -
Efficient Enrichment of Retinal DHA with Dietary Lysophosphatidylcholine-DHA: Potential Application for Retinopathies
por: Sugasini, Dhavamani, et al.
Publicado: (2020)